E Fund Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-339,994	Closed	-$561K	–	413
2024 Q4	$561K	Sell	339,994 -13,777	-4%	-$34.7K	0.03%	209
2024 Q3	$1.24M	Sell	353,771 -1,454	-0.4%	-$5.66K	0.06%	126
2024 Q2	$1.17M	Buy	355,225 +320,745	+930%	+$1.4M	0.06%	113
2024 Q1	$253K	Buy	+34,480	New	+$213K	0.02%	298
2023 Q3	–	Sell	-51,350	Closed	-$244K	–	302
2023 Q2	$244K	Sell	51,350 -27,787	-35%	-$153K	0.02%	252
2023 Q1	$451K	Buy	79,137 +56,781	+254%	+$343K	0.03%	135
2022 Q4	$226K	Buy	22,356 +5,404	+32%	+$101K	0.02%	281
2022 Q3	$380K	Sell	16,952 -5,151	-23%	-$149K	0.04%	194
2022 Q2	$548K	Buy	22,103 +14,107	+176%	+$389K	0.05%	129
2022 Q1	$310K	Buy	7,996 +4,468	+127%	+$173K	0.01%	187
2021 Q4	$206K	Buy	+3,528	New	+$200K	0.01%	257